A systematic review of the efficacy and safety of mucolytics in patients with stable chronic obstructive pulmonary disease
Not Applicable
- Conditions
- chronic obstructive pulmonary disease(COPD)
- Registration Number
- JPRN-UMIN000053404
- Lead Sponsor
- Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects with chronic bronchitis without evidence of fixed airflow limitation (FEV1%<70) Subjects started on mucolytics as a treatment for COPD exacerbations Asthma and chronic obstructive pulmonary disease (COPD) overlap (ACO)
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method COPD exacerbations hospitalization
- Secondary Outcome Measures
Name Time Method duration of antimicrobial therapy duration of exacerbation duration of disability time to first exacerbation St. George's Respiratory Questionnaire score forced expiratory volume in one second forced vital capacity adverse events serious adverse events mortality cost-effectiveness